The Drugs Controller General of India (DCGI,) on the 10th of August, approved the study of mixing the doses of Covishield and COVAXIN. The approval came after the recent research…
After the two India made vaccines, the Indian Council of Medical Research (ICMR) said, the mix of two Indian vaccine is safe and better immunity against the Novel Coronavirus (COVID-19)…
The Hyderabad based Bharat Biotech International Private Limited manufactured COVAXIN has been found effective against the new Delta Plus variant of the Wuhan virus. The latest development regarding the Novel…
On the 22nd of May, a team led by the AYUSH Commissioner Ramulu Naik started studying Ayurvedic expert Anandiah’s Ayurvedic medicine for the Wuhan virus patients. Prepared by a local…
Hyderabad based pharma company, Bharat Biotech International Private Limited and the Indian Council Medical Research (ICMR) prepared vaccine, for the Novel Coronavirus or COVID-19 entered the third phase of the…
The Nizam’s Institute of Medical Sciences (NIMS) of Hyderabad started the phase-III human clinical trials for COVAXIN. The trials begin from the 16th of November. A medical team at NIMS…
On the 12th of September, Hyderabad based Bharat Biotech’s Novel Coronavirus or COVID-19 vaccine candidate COVAXIN, showed successful results on animals. According to the sources, the potential vaccine showed efficacy…
On the 27th of July, Prime Minister Narendta Modi launched ‘high throughput’ COVID-19 testing facilities at the Indian Council of Medical Research (ICMR) centres in Mumbai, Noida and Kolkata. The…
After Indian Council of Medical Research Council (ICMR,) declared COVID-19 Antibody rapid blood test kits for Coronavirus faulty, the Chinese Government responded and said India to be irresponsible China said…
The Indian Council of Medical Research (ICMR,) on the 27th of April, asked state governments to stop using rapid test kits for the Novel Coronavirus infection from China. Kits from…
